Even One Drink Daily Raises Risk for Ten Cancers, Study

Think one glass is harmless? New evidence suggests that small, familiar comforts can carry surprising costs.

A large, careful review led by researchers at the University of Washington and published in Nature Health examined the link between alcohol and health across decades of research. The team sifted through 843 studies conducted from 1963 to 2023, comparing alcohol intake with 20 major health outcomes. The approach was methodical: each relationship was graded on a zero-to-five star scale to show how strong and consistent the evidence is.

Even less than one drink a day was tied to higher risks for all ten cancers the authors studied.

Which cancers? The paper highlights harmful associations for a range of tumors, including pharyngeal, colorectal, esophageal, breast, liver, pancreatic and prostate cancers. In most cases the pattern was clear — more alcohol, more risk — but crucially, the increase in risk was detectable even at low consumption levels.

Alcohol’s footprint extended beyond cancer. Heavy drinking was linked to elevated risk across all 20 conditions analyzed, from chronic liver disease, pancreatitis and cirrhosis to infectious respiratory illnesses. For cardiovascular, metabolic and neurological outcomes the picture was more complicated. Low-to-moderate intake sometimes correlated with slightly lower risks of conditions such as type 2 diabetes and Alzheimer’s, but those apparent benefits faded or reversed as consumption rose.

Why the caution? The authors stress that the science is complex and context matters. Drinking was self-reported in most of the reviewed studies, and how each study controlled for other factors — smoking, diet, socioeconomic status — varied widely. Those caveats aside, the scale and consistency of the cancer findings stand out, and the researchers used a conservative analysis strategy that likely understates, rather than overstates, harm.

Public-health implications are obvious but hard to pin down into a single global rule. Patterns of disease burden differ by age and region, and recommended drinking thresholds already vary from country to country. The research team argues for honesty in public messaging: guidance should reflect where the evidence is strong, where it is mixed, and the specific risks that matter most to each population.

So what should an individual do? That is a personal choice shaped by family history, overall health and values. But after a review of hundreds of studies spanning sixty years, the take-home is plain: even modest daily drinking is not risk-free. Is that glass of wine at dinner still worth it?